Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

A specific type of skin cell creates an opening for hair to grow out, and problems with this process can lead to skin conditions.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Genetic mutations can cause hair growth disorders by affecting key genes and signaling pathways.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 may harm male fertility and damage the reproductive system.

New understanding and treatments for hair loss are improving, but more research is needed.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Understanding keratinization is crucial for treating skin conditions like ichthyoses and psoriasis.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Certain genes in Iranian sheep are linked to wool production and heat adaptation.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.